AP

Abhishek Pathak

Active Director Director DIN 09274288
DIN 09274288 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Abhishek Pathak

Data last updated:

Abhishek Pathak is a Director at Medimerk Pharma Private Limited (since 2021). The company operates in Chemicals. Medimerk Pharma Private Limited reported revenue of ₹5.6 Lakh (FY 2022).

DIN 09274288
Primary Designation Director
Industry Chemicals
First Appointment 09 Aug 2021
Oldest Company Age 5 yrs
Largest company Medimerk Pharma Private Limited · ₹5.6 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medimerk Pharma Private Limited U24230MH2021PTC365551
Director09 Aug 20212021₹5.6 Lakh (FY 2022)Active

Board colleagues of Abhishek Pathak

Directorship timeline

Open interactive timeline →
Medimerk Pharma Private Limited
Premium access

Shareholding and investment profile for Abhishek Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Pathak

Abhishek Pathak currently holds 1 directorship: Medimerk Pharma Private Limited (Director, since 09 Aug 2021, revenue ₹5.6 Lakh (FY 2022)).

Abhishek Pathak was first appointed on 09 Aug 2021 as Director at Medimerk Pharma Private Limited.

The current boards of Abhishek Pathak's companies include Reenu Pradeep Pandey (Medimerk Pharma Private Limited), Roshni Yaduvendra Pratap Singh (Medimerk Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available